Cargando…
Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases
BACKGROUND: Serotonin syndrome is a toxic state, caused by serotonin (5HT) excess in the central nervous system. Serotonin syndrome’s main feature is neuro-muscular hyperexcitability, which in many cases is mild but in some cases can become life-threatening. The diagnosis of serotonin syndrome remai...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941011/ https://www.ncbi.nlm.nih.gov/pubmed/27406219 http://dx.doi.org/10.1186/s12883-016-0616-1 |
_version_ | 1782442233380732928 |
---|---|
author | Werneke, Ursula Jamshidi, Fariba Taylor, David M. Ott, Michael |
author_facet | Werneke, Ursula Jamshidi, Fariba Taylor, David M. Ott, Michael |
author_sort | Werneke, Ursula |
collection | PubMed |
description | BACKGROUND: Serotonin syndrome is a toxic state, caused by serotonin (5HT) excess in the central nervous system. Serotonin syndrome’s main feature is neuro-muscular hyperexcitability, which in many cases is mild but in some cases can become life-threatening. The diagnosis of serotonin syndrome remains challenging since it can only be made on clinical grounds. Three diagnostic criteria systems, Sternbach, Radomski and Hunter classifications, are available. Here we test the validity of four assumptions that have become widely accepted: (1) The Hunter classification performs clinically better than the Sternbach and Radomski criteria; (2) in contrast to neuroleptic malignant syndrome, the onset of serotonin syndrome is usually rapid; (3) hyperthermia is a hallmark of severe serotonin syndrome; and (4) serotonin syndrome can readily be distinguished from neuroleptic malignant syndrome on clinical grounds and on the basis of medication history. METHODS: Systematic review and meta-analysis of all cases of serotonin syndrome and toxicity published between 2004 and 2014, using PubMed and Web of Science. RESULTS: Two of the four assumptions (1 and 2) are based on only one published study each and have not been independently validated. There is little agreement between current criteria systems for the diagnosis of serotonin syndrome. Although frequently thought to be the gold standard for the diagnosis of the serotonin syndrome, the Hunter criteria did not perform better than the Sternbach and Radomski criteria. Not all cases seem to be of rapid onset and only relatively few cases may present with hyperthermia. The 0 differential diagnosis between serotonin syndrome and neuroleptic malignant syndrome is not always clear-cut. CONCLUSIONS: Our findings challenge four commonly made assumptions about serotonin syndrome. We propose our meta-analysis of cases (MAC) method as a new way to systematically pool and interpret anecdotal but important clinical information concerning uncommon or emergent phenomena that cannot be captured in any other way but through case reports. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12883-016-0616-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4941011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49410112016-07-13 Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases Werneke, Ursula Jamshidi, Fariba Taylor, David M. Ott, Michael BMC Neurol Research Article BACKGROUND: Serotonin syndrome is a toxic state, caused by serotonin (5HT) excess in the central nervous system. Serotonin syndrome’s main feature is neuro-muscular hyperexcitability, which in many cases is mild but in some cases can become life-threatening. The diagnosis of serotonin syndrome remains challenging since it can only be made on clinical grounds. Three diagnostic criteria systems, Sternbach, Radomski and Hunter classifications, are available. Here we test the validity of four assumptions that have become widely accepted: (1) The Hunter classification performs clinically better than the Sternbach and Radomski criteria; (2) in contrast to neuroleptic malignant syndrome, the onset of serotonin syndrome is usually rapid; (3) hyperthermia is a hallmark of severe serotonin syndrome; and (4) serotonin syndrome can readily be distinguished from neuroleptic malignant syndrome on clinical grounds and on the basis of medication history. METHODS: Systematic review and meta-analysis of all cases of serotonin syndrome and toxicity published between 2004 and 2014, using PubMed and Web of Science. RESULTS: Two of the four assumptions (1 and 2) are based on only one published study each and have not been independently validated. There is little agreement between current criteria systems for the diagnosis of serotonin syndrome. Although frequently thought to be the gold standard for the diagnosis of the serotonin syndrome, the Hunter criteria did not perform better than the Sternbach and Radomski criteria. Not all cases seem to be of rapid onset and only relatively few cases may present with hyperthermia. The 0 differential diagnosis between serotonin syndrome and neuroleptic malignant syndrome is not always clear-cut. CONCLUSIONS: Our findings challenge four commonly made assumptions about serotonin syndrome. We propose our meta-analysis of cases (MAC) method as a new way to systematically pool and interpret anecdotal but important clinical information concerning uncommon or emergent phenomena that cannot be captured in any other way but through case reports. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12883-016-0616-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-12 /pmc/articles/PMC4941011/ /pubmed/27406219 http://dx.doi.org/10.1186/s12883-016-0616-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Werneke, Ursula Jamshidi, Fariba Taylor, David M. Ott, Michael Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases |
title | Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases |
title_full | Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases |
title_fullStr | Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases |
title_full_unstemmed | Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases |
title_short | Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases |
title_sort | conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941011/ https://www.ncbi.nlm.nih.gov/pubmed/27406219 http://dx.doi.org/10.1186/s12883-016-0616-1 |
work_keys_str_mv | AT wernekeursula conundrumsinneurologydiagnosingserotoninsyndromeametaanalysisofcases AT jamshidifariba conundrumsinneurologydiagnosingserotoninsyndromeametaanalysisofcases AT taylordavidm conundrumsinneurologydiagnosingserotoninsyndromeametaanalysisofcases AT ottmichael conundrumsinneurologydiagnosingserotoninsyndromeametaanalysisofcases |